CEACAM1 and Insulin resistance: As abdominal obesity and insulin resistance progress, the pulsatility of insulin release decreases [8,9], leading to defective insulin signaling in hepatocytes, including CEACAM1 phosphorylation and, subsequently, reduction in hepatic insulin clearance to contribute to chronic hyperinsulinemia.